Achieving higher pathological complete response rates in HER-2-positive patients with induction chemotherapy without trastuzumab in operable breast cancer. (Q38432663)
Jump to navigation
Jump to search
scientific article published on April 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Achieving higher pathological complete response rates in HER-2-positive patients with induction chemotherapy without trastuzumab in operable breast cancer. |
scientific article published on April 2007 |
Statements
Achieving higher pathological complete response rates in HER-2-positive patients with induction chemotherapy without trastuzumab in operable breast cancer (English)
Marie-Ange Mouret-Reynier
Inès Raoelfils
Marianne Leheurteur
Pierre Gimbergues
Jacques Tortochaux
Hervé Curé
Philippe Chollet
Frédérique Penault-Llorca
1 April 2007